Safety and Efficacy of Levamisole in Loiasis: A Randomized, Placebo-controlled, Double-blind Clinical Trial

BACKGROUND: Individuals with high microfilarial densities (MFDs) of Loa loa are at risk of developing serious adverse events (SAEs) after ivermectin treatment. Pretreatment with drugs progressively reducing Loa MFDs below the risk threshold might help prevent these SAEs. We assessed the safety and e...

Descripción completa

Detalles Bibliográficos
Autores principales: Campillo, Jérémy T, Bikita, Paul, Hemilembolo, Marlhand, Louya, Frédéric, Missamou, François, Pion, Sébastien D S, Boussinesq, Michel, Chesnais, CédricB
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402607/
https://www.ncbi.nlm.nih.gov/pubmed/34651190
http://dx.doi.org/10.1093/cid/ciab906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402607/
https://www.ncbi.nlm.nih.gov/pubmed/34651190
http://dx.doi.org/10.1093/cid/ciab906

Ejemplares similares